COURTNEY BROWN: Open Payments
NPI 1538776109 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,845 in 136 payments from 19 companies in 2025. Trend: 2023 $5,198 · 2024 $4,857 · 2025 $2,845
Food & beverage: $2,661Education: $184
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $608 |
| PFIZER INC. | 27 | $346 |
| Lilly USA, LLC | 7 | $339 |
| GENZYME CORPORATION | 9 | $291 |
| Galderma Laboratories, L.P. | 12 | $256 |
| Arcutis Biotherapeutics, Inc. | 12 | $217 |
| Janssen Biotech, Inc. | 3 | $142 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $120 |
| Organon LLC | 12 | $104 |
| Astellas Pharma US Inc | 5 | $91 |
Products named: CIBINQO, DUPIXENT, BOTOX, Zoryve, EBGLYSS, TALTZ, TREMFYA, SKYRIZI.
Industry payments across TX — which companies pay providers there.
